Mylan Issues EpiPen Recall Due To Potential Defect

The EpiPen intervention product administers doses of epinephrine to patients suffering from anaphylaxis resulting from extreme allergic reactions.

"What they're asking consumers to do is to check to see if their EpiPens are in these lots, and if so, to send them back so they can send replacements", Childs said.

So far, the US recall covers 13 EpiPen lots distributed from December 17, 2015, to July 1, 2016. Mylan calls the incidents "extremely rare," but in the case of a life-saving drug that is administered in emergency situations even one defective product is too many.

Neymar scores incredible goal as Brazil book world cup spot
Brazil no longer depend exclusively on Neymar, and can play without teenage target man Gabriel Jesus and still score goals. Brazil sealed their ticket to Russian Federation with a comprehensive 3-0 win over Paraguay .

Mylan has caught a lot of heat over the past year for raising prices on consumers. The device is a literal lifesaver for people who experience severe allergic reactions, and that's exactly why the company is being pro-active about the issue. The Jr Auto-Injector expires in March 2017 and lot number 5GR765.

"The potential defect could make the device hard to activate in an emergency and have significant health consequences for a patient experiencing a life-threatening allergic reaction", Mylan said in a statement Friday. Mylan said it plans to replace the recalled EpiPens at no cost to patients. (0.15 mg) 2-packs shipped in the United States that are now included in a voluntary recall.

Consumers should keep and use their EpiPen until they have a replacement.

  • Darren Santiago